D-Dimer and Outcomes in Hospitalized Heart Failure Patients Across the Ejection Fraction Phenotypes
Open Access
- 23 June 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 9 (5) , 3060-3070
Abstract
Aims: The prognostic significance of D-dimer in hospitalized heart failure (HF) patients is incompletely characterized. We aimed to assess the association of D-dimer levels on admission with adverse events at follow-up in patients hospitalized with HF across all ejection fraction (EF) phenotypes. Methods and results: Consecutive patients hospitalized from December 2006 to December 2017 for HF with D-dimer and EF values available (n = 1795) were enrolled. Associations between D-dimer and all-cause death were examined at 1-year follow-up. Median age was 57 years, 73.4% were male, and the majority (72.1%) were in New York Heart Association Classes III–IV. EF was reduced in 53.3% (HFrEF), mildly reduced in 16.3% (HFmrEF), and preserved in 30.4% (HFpEF). Median (interquartile range) D-dimer on admission was 0.56 (0.27–1.295) μg/mL FEU (fibrinogen-equivalent unit) in the whole cohort, 0.64 (0.28–1.48) μg/mL FEU in HFrEF, 0.50 (0.27–1.03) μg/mL FEU in HFmrEF, and 0.495 (0.25–1.10) μg/mL FEU in HFpEF (P = 0.001). At 1-year follow-up, higher D-dimer (D-dimer ≥0.56 μg/mL FEU) independently predicted all-cause death in total cohort [hazard ratio (HR) 1.55; 95% confidence interval (CI), 1.15–2.1], in HFrEF (HR, 1.49; P = 0.039), and in HFpEF (HR, 2.06; P = 0.033). However, no relationship was found for HFrEF or HFmrEF when D-dimer was treated as quartiles. In sensitivity analysis, quantitatively similar but more pronounced association between D-dimer and all-cause death was observed in total cohort and HFpEF cohort. Conclusions: In hospitalized HF patients, higher D-dimer concentration was a significant and independent predictor of 1-year all-cause mortality. Across all HF phenotypes, this effect was most evident in HFpEF patients.Keywords
Funding Information
- Key Projects in the National Science and Technology Pillar Program of the 13th Five-Year Plan Period, Beijing, People's Republic of China (2017YFC1308300)
This publication has 46 references indexed in Scilit:
- Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challengesInternational Journal of Cardiology, 2013
- Thromboembolism and antithrombotic therapy for heart failure in sinus rhythmThrombosis and Haemostasis, 2012
- Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patientsJournal of Hospital Medicine, 2011
- Venous Thromboembolism in Hospitalized Patients With Heart FailureCirculation: Heart Failure, 2010
- Diagnosis of Acute Aortic Dissection by D-DimerCirculation, 2009
- D-dimer antigen: current concepts and future prospectsBlood, 2009
- Risk of Venous Thromboembolism in Patients Hospitalized With Heart FailureThe American Journal of Cardiology, 2006
- Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trialBMJ, 2006
- Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failureThrombosis and Haemostasis, 2004
- Platelet function, thrombin and fibrinolytic activity in patients with heart failureEuropean Heart Journal, 1993